Zenicor Medical Systems AbNGM: ZENI

ZENI: Revenue growth and positive operating income mark a strong Q3, despite liquidity challenges

· Issued by Zenicor Medical Systems AB

Q3 2024 saw 4% revenue growth and a return to positive operating income, with EBITDA at 1,104 KSEK. Liquidity remains a challenge, but new contracts and ongoing projects support a positive outlook.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Zenicor Medical Systems Ab

All Zenicor Medical Systems Ab news releases